Beef

© istock

EFSA weighs in on safety of beta agonist for cattle

By Jane Byrne

EFSA found the available literature investigating the effects of the feed additive, zilpaterol, on animal health and welfare is limited but indicates a potential increase in mortality, heart rate, respiration rate and agonistic behavior in cattle.

No immediate plans to put Zilmax back on US market: Merck

No immediate plans to put Zilmax back on US market: Merck

By Jane Byrne

Zilmax maker Merck says it has not made any decision to resume sales of the cattle additive in the US as a campaign group there condemns the company for “taking steps” to put the beta agonist back on the market.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All